Phase 1/2a study of MYO-101.
Phase of Trial: Phase I/II
Latest Information Update: 20 Dec 2017
At a glance
- Drugs MYO 101 (Primary)
- Indications Sarcoglycanopathies
- Focus Therapeutic Use
- 20 Dec 2017 New trial record
- 13 Dec 2017 Accrding to a Myonexus Therapeutics media release, this trial will initiate in early 2018.